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The Rous sarcoma virus (RSV) Gag polyprotein is the only protein required for virus assembly and release. We previously found that deletion
of either one of the two Cys–His (CH) motifs in the RSV nucleocapsid (NC) protein did not abrogate Gag–Gag interactions, RNA binding, or
packaging but greatly reduced virus production (E-G. Lee, A. Alidina et al., J. Virol. 77: 2010–2020, 2003). In this report, we have further
investigated the effects of mutations in the CH motifs on virus assembly and release. Precise deletion of either CH motif, without affecting
surrounding basic residues, reduced virus production by approximately 10-fold, similar to levels seen for late (L) domain mutants. Strikingly,
transmission electron microscopy revealed that virions of both DCH1 and DCH2 mutants were assembled normally at the plasma membrane but
were arrested in budding. Virus particles remained tethered to the membrane or to each other, reminiscent of L domain mutants, although the
release defect appears to be independent of the L domain functions. Therefore, two CH motifs are likely to be required for budding independent of
a requirement for either Gag–Gag interactions or RNA packaging.
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Orthoretrovirus assembly and release are totally dependent
on the Gag protein. Gag is synthesized as a polyprotein
composing at least three main domains including the matrix
(MA), capsid (CA), and nucleocapsid (NC) and several others
that differ among viral genera. In Rous sarcoma virus (RSV), a
prototype of the Alpharetroviruses, protease (PR) which is
encoded at the carboxy-terminus of the Gag polyprotein
becomes activated during, or right after, virus budding and
cleaves Gag into its respective domains: MA, CA, p2, p10, NC,
and PR. RSV is a C-type retrovirus so that plasma membrane is
the main site for virus assembly and release. There are three
assembly domains in Gag. The M domain is located at the N-
terminus of MA required for targeting and binding of Gag to
the plasma membrane. The interaction (I) domain resides at NC
and is responsible for the Gag–Gag interactions required to
make capsid cores. It is now clear that clustered basic residues0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: mlinial@fhcrc.org (M.L. Linial).in NC function as a scaffold to nucleate Gag by binding to
nucleic acids. The late (L) domain is required for completion of
assembly and release.
L domains are found in many different families of
enveloped RNA viruses, including retroviruses, filoviruses,
and rhabdoviruses (reviewed in Freed, 2002). Three consensus
sequences have been identified as L domains, and each of these
binds to different cellular proteins (Pornillos et al., 2002;
Bouamr et al., 2003; Martin-Serrano et al., 2003; Strack et al.,
2003). A number of studies suggest that these interactions
facilitate the recruitment of distinct subsets of the cellular
machinery involved in endosomal protein sorting, which are
also required for virus release (reviewed in Morita and
Sundquist, 2004). The L domain of RSV is a PPPY motif
located within the p2 domain of Gag (Parent et al., 1995),
which has been shown to bind to proteins related to the Nedd4
family of ubiquitin protein ligases (Kikonyogo et al., 2001).
Ubiquitination, which is well known to serve as an initial signal
for endocytosis and subsequent endosomal protein trafficking,
also appears to play important roles in virus budding, although
some late domains function in a ubiquitin-independent manner
(Patnaik et al., 2002).6) 226 – 233
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the conserved sequences Cys-X2-Cys-X4-His-X4-Cys (Cys–
His [CH] motif), which coordinates Zn2+ ion binding and
clustered basic residues flanking the CH motif(s). NC plays
important roles in many steps of virus replication such as
reverse transcription, integration, RNA packaging, and virus
assembly (Darlix et al., 1995; Rein et al., 1998). A number of
studies from our laboratory and others have demonstrated that
the stretches of basic residues (BRs) within NC, rather than the
CH motifs, play key roles in Gag multimerization by binding to
RNA (Lee et al., 2003; Lee and Linial, 2004; Yu et al., 2001;
Muriaux et al., 2002; Dawson and Yu, 1998; Cimarelli et al.,
2000; Bowzard et al., 1998). However, proper conformation of
CH motifs surrounding the BRs in the tertiary Gag protein
structure appears essential for the interaction of Gag with its
cognate genomic RNA packaging signal. Thus, the functions of
NC in assembly and RNA packaging are closely coupled.
In previous studies, we found that deletion of both of the
CH motifs in RSV NC reduced the efficiency of particle
release, as well as specific RNA packaging, by 6- to 10-fold
(Lee et al., 1999). However, the deletion of either one, or both,
of the CH motifs did not abrogate Gag–Gag interactions (Lee
and Linial, 2004). In this report, we have examined the effect
of NC CH motifs on virus assembly and release. Using electron
microscopy, we found that deletion of either CH motif leads to
late domain mutant-like phenotypes. Virus assembly is arrested
at a late stage of budding so that particles remain attached to
the plasma membrane or tethered to each other. The results are
similar to a recent report that some mutations in murine
leukemia virus (MLV) NC led to defects in release steps of
virion production (Muriaux et al., 2004). However, our results
with RSV NC mutants show distinct differences from those
obtained with MLV, where the mutants also affected RNA
packaging, which in itself can have a profound effect on viral
assembly.
Results
Deletion of either one of the two Cys–His motifs does not
abrogate cellular expression of Gag but impairs virus particle
production
Our previous studies showed that deletion of both the CH
motifs in NC reduced the efficiency of particle release as well
as specific RNA packaging by 6- to 10-fold (Lee et al., 1999).
However, the deletion of only one of the two CH motifs did not
affect RNA binding or packaging, although virus release was
impaired (Lee et al., 2003). Yeast two-hybrid assays indicated
that deletion of either one or both of the two CH motifs did not
abrogate Gag–Gag interactions between wild type or the
cognate mutant Gag (Lee and Linial, 2004). In order to
examine whether DCH mutants allow efficient release of virus
particles into culture supernatants, each of the two CH motifs
was deleted in the full-length RSV proviral vector, GagDPR
(Lee and Linial, 2004), lacking the entire protease domain (Fig.
1A). This vector was previously used to examine the effects of
DCH mutations by yeast two-hybrid and genomic RNApackaging assays. QT6 cells stably transfected with mutant
or wt proviral DNAs were labeled with [35S]-methionine, and
cells and cell-free culture supernatants were collected. Labeled
viral proteins from cells and extracellular particles were
detected by RIPA using polyclonal antiserum against whole
virions. The DCH1 and DCH2 mutants show similar levels of
cell-associated viral proteins as those observed for the wild
type, DPR, however, virus release into the media is greatly
decreased (Fig. 1B). The efficiency of virus release was
determined by calculating the amount of Gag proteins in
virions normalized to that of Gag proteins in the cells. The
amount of Gag released into the supernatant is decreased about
ten-fold compared to wt (Fig. 1C), which is similar to that seen
with the late domain-negative mutant of HIV-1 and RSV
(Gottlinger et al., 1991; Xiang et al., 1996).
Mutations in NC impair virus budding from the plasma
membrane
The reduction in virus release shown by the DCH mutants
might be caused by an inability of mutated Gag proteins to
assemble at the plasma membrane or by a defect in budding. To
differentiate between these two stages, thin sections were made
from QT6 cells stably transfected with plasmids encoding
either DPR wild type NC virus or mutant NCs and were
examined by transmission electron microscopy. In the case of
the wt control (DPR), electron-dense material is seen to
accumulate at the plasma membrane, and particles are seen
budding from the membrane (Fig. 2A). The particles produced
by DPR have the immature phenotype expected in the absence
of protease (Fig. 2B, arrows). Deletion of either CH motif,
however, leads to defects in virus budding. Virions assembled
normally at the membrane, but virus release is arrested during
budding, with particles remaining attached to the membrane or
to other particles (Fig. 2C, filled arrows). Normally, spherical
particles are released from the cell when the membrane neck is
pinched off behind the assembled particles. However, mutant
particles retain the short stalk connecting membranes between
viruses and producing cells. In some cases, two or three virions
are attached to each other. The budding phenotype is very
similar to those seen in viruses with mutations in the late
domain of other retroviruses such as HIV-1, RSV, and MLV
(Gottlinger et al., 1991; Wills et al., 1994; Yuan et al., 2000),
where particles are seen tethered to the membrane or to other
particles to form interconnected ones. We examined many
different fields and found that about 80% of the particles
produced by DCH mutants fail to complete budding, whereas
approximately 10% of particles are extracellular and resemble
those of wt (Fig. 2C, unfilled arrows). Interestingly, we also
often found virus-like particles in vesicles located near the
plasma membrane (Fig. 2D). The size of particle-like structures
is similar to that of RSV virions, with an approximate diameter
of 100 nm, and these contain the typical inner dark ring
underneath a viral membrane seen in protease-deficient PR-
virions. In addition, we often found small invaginations of the
plasma membrane that seem to be coated with electron-dense
material at the periphery in cells transfected with DCH mutant
Fig. 1. (A) Gag constructs used in this study and summary of their effects on Gag–Gag interactions and RNA packaging. Deletion of either CH motif was made in
the context of GagDPR (the dotted box indicates the region of Gag that has been deleted). The amino acid sequence of NC is shown from the amino terminus of NC.
The positively charged residues are indicated in boldface type, and the two CH motifs are boxed in gray. Interactions of the DCH mutants with either wt or cognate
mutant Gag were previously determined by yeast two-hybrid binding assays to measure the transcriptional activation of a reporter gene, lacZ (Lee and Linial, 2004).
+ indicates that colonies turned dark blue in a 1 h incubation at 30 -C. The RNA packaging efficiencies of the DCH mutants are summarized (Lee et al., 2003). (B)
Efficiency of virus production determined by RIPA. [35S]-methionine-labeled cell lysates and pelleted virus particles collected from supernatants were
immunoprecipitated with polyclonal anti-RSVantiserum, subjected to RIPAwith anti-RSVantiserum, and analyzed on SDS-10% polyacrylamide gels. (C) Efficiency
of virus production was calculated by normalizing the levels of viral Gag proteins with those of cellular Gag and is shown as the ratio relative to DPR wt. The
average from four independent assays is shown. The efficiencies relative to DPR are shown above the bars.
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mock- or DPR-transfected cells.
In order to confirm that some of the intracellular structures
seenwith themutants containedGag, we performed immunogold
labeling of cells using a monoclonal antibody reactive against the
first 50 amino acids of RSVMA. No gold labeling is observed in
thin sections of mock-transfected cells (data not shown). In the
wild-type-transfected cells, we detect specific gold labeling of
budding particles at the cell surface as well as extracellular
particles (Fig. 3A, arrows). In cells transfected with DCHmutant
DNAs, label is seen at the plasma membrane in conjunction with
spherical particles, but these were not fully separated from the
cells but remain attached to the membrane (Fig. 3B, arrow).
Sometimes, multiple particles are associated with each other
(Fig. 3C, arrows) or connected to the cell membrane through
membranous stalks (Fig. 3D, arrow). In general, mutant gold
labeled particles are uniform in size and shape, similar to those
seen for wt particles. We also tried to determine whether the
electron-dense membrane invaginations that are frequently
observed in mutant transfected cells contain viral proteins.
However, under the fixation conditions, which are optimized for
preservation of ultrastructures and efficient antigen detection,
these structures are not preserved. Instead, we detect structures
resembling collapsed invaginations underneath the membrane
which specifically labeledwith gold (Fig. 3E, arrow). In addition,
gold label is found near the membrane, and intracellular particlesare frequently observed in the cytoplasm (Fig. 3F, arrow). We
also could confirm that the VLPs in vesicles near the plasma
membrane are specifically labeled with gold (Fig. 3G, arrow).
Taken together, these EM studies reveal two major
phenotypes in cells expressing GagDCH. First, Gag proteins
assembled in the plasma membrane, but budding is arrested,
resulting in particles tethered to the membrane or to each other.
Second, intracellular particles are often found in the cytoplasm
and in the vesicles near the membrane. Thus, although neither
CH motif is required for virus assembly, two motifs are
required for normal budding.
The DCH budding phenotype is independent of the late domain
functions
A number of studies using many retroviruses have shown
that cellular factors required for endosomal protein trafficking
are also involved in virus budding, and ubiquitination, which
serves as an initial signal for protein sorting pathways, plays
important roles in virus release (reviewed in Morita and
Sundquist, 2004). Screening of a chicken cDNA library
identified an RSV late domain interaction (LDI) protein, which
contains WW domains similar to those found in the Nedd4
family of E3 protein ubiquitin ligases (Kikonyogo et al., 2001).
Gag proteins lacking a CH motif might undergo conforma-
tional changes, resulting in impaired binding of the RSV p2
Fig. 2. Transmission electron micrographs of QT6 cells stably transfected with the wt proviral vector (GagDPR) (A–B) or DCH1 mutant (C–D) or DCH2 mutant
(E). The scale bar represents 0.2 Am.
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assay was used to measure the interactions between mutant
Gag proteins and LDI protein, using a h-Gal filter assay. As a
negative control for binding, a mutant deleted of the p2 L
domain was constructed. The Dp2 mutant does not bind to LDI
protein in this assay (Table 1). However, Gag lacking either CH
motif interacts with LDI protein equally as well as wt Gag
(GagDPR). We also examined whether depletion of cellular
ubiquitin can affect virus release from the DCH mutants. QT6
cells stably transfected with DCH mutants were treated with a
proteasome inhibitor (MG 132) that reduces the level of free
ubiquitin in the cell. The virus production of DPR wt NC
treated with the drug reaches about 15% of the level of
untreated cells, similar to the levels seen in other studies
(Patnaik et al., 2000). However, the drug does not furtherreduce virus release from either DCH mutant (Fig. 4), showing
that the small number of particles that are released are
independent of ubiquitination. We hypothesize that release
defects in the DCH mutants do not involve the same cellular
interaction pathway as that defined by the L domain. However,
it is also possible that deletion of a CH motif leads to
conformational changes in Gag, which prevent binding to the
normal complement of cellular factors required for release. The
evidence against this is the binding of the DCH mutants to the
LDI protein in a yeast two-hybrid assay.
Discussion
In this study, we have examined the role of Alpharetrovirus
NC Cys–His motifs in virus assembly and release. We found
Fig. 3. Immunoelectron micrographs of QT6 cells stably transfected with DPR wt (A) or DCH1 (B–C, and G) or DCH2 (D–F). The scale bar represents 0.2 Am.
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to a ca. 10-fold reduction in virus release, without affecting
intracellular Gag expression. EM studies revealed buddingTable 1
Interactions between Gag and LDI proteins determined using a yeast two-
hybrid binding assay






A qualitative h-Gal filter assay was used to measure protein –protein
interactions: ++++, colonies turn dark blue within 1 h; +++, 2 h; +/, longer
than 5 h. For details, see Materials and methods.defects similar to those seen in L domain deficient mutants.
Mutant virus particles remained attached to the plasma
membrane or to other particles.
These studies were done with virus lacking viral protease.
Protease processing of Gag and virus budding are temporally
linked during virus assembly. HIV-1 release was delayed when
protease activity was blocked by mutations, suggesting that the
proper proteolytic activity was required for efficient virus
release (Kaplan et al., 1994). Additionally, HIV-1 budding
defects caused by L domain deletions could be complemented
by protease inactivation (Huang et al., 1995). However,
protease activation during virus budding is unlikely to play a
role in RSV particle release because budding efficiency
remained unaltered in the presence or absence of PR (Wills
et al., 1994; Stewart et al., 1990). We also examined the effects
of deletion of one CH motif on virus release in the context of
Fig. 4. Proteasome inhibitor assay. QT6 cells stably transfected with either DPR wt or DCH proviral DNAs were either untreated or treated with MG132 for 90 min
prior to and during [35S]-methionine labeling as described in Materials and methods. Gag proteins from cell lysates and virus particles pelleted from supernatants
were subjected to RIPA and analyzed on SDS-10% polyacrylamide gel.
E.-G. Lee, M.L. Linial / Virology 347 (2006) 226–233 231wt PR and found that the decrease in efficiency of virus release
is not affected by the presence of viral protease. We found a 7-
to 8-fold reduction in DCH virus release compared to wt in a
PR+ background (data not shown), although we did not
examine the PR+ particles by electron microscopy.
Deletion of NC from RSV Gag abolished formation and
budding of virus-like particles (VLPs), whereas replacement of
NC with a leucine zipper (mimicking an I domain) allowed
production of VLPs (Johnson et al., 2002; Zhang et al., 1998).
EM images of chimeric RSV Gag containing a leucine zipper
showed that the VLPs were quite similar in appearance to wt.
Spherical particles were properly formed at the plasma mem-
brane, but many VLPs fused into long chains and aggregates of
merged spheres at the membrane surface (Johnson et al., 2002).
Such aberrant morphology is similar to the budding phenotypes
seen with our DCH mutants. Taken together, the results suggest
that NC can be deleted without compromising virus assembly as
long as I domain function is provided, but NC is required for
virus release from the membrane. Most previous studies have
assigned an obligate role to NC in virus assembly and release (Yu
et al., 2001; Cimarelli et al., 2000; Muriaux et al., 2004; Lee and
Linial, 2004). However, in one report, deletion of NC from a full-
length HIV-1 proviral clone did not prevent production of virus
particles, although the efficiencywas decreased (Ott et al., 2003).
This group has shown that an RNA binding site in the HIV-1MA
protein can compensate for deletion of NC (Ott et al., 2005).
The phenotype of the RSVDCH mutants reported here is
similar to that found for mutants of MLV NC, which normally
contains only one CH motif (Muriaux et al., 2004). MLV NC
mutants lacking either the clustered BRs alone or the distal
portion of NC (including the CH motif and 3V BRs) showed
greatly impaired virus release. EM studies revealed morpho-
logically aberrant virions, and the phenotype of the larger
deletion mutant closely resembled that of MLV L domain
mutants. However, there are important differences between our
results and those of Muriaux et al. (2004). The MLV NC
mutants also abolished RNA packaging, whereas the RSV
budding defect we report is independent of genomic RNA
packaging. Binding of Gag to RNA is an important step in viral
assembly (Ma and Vogt, 2004; Muriaux et al., 2002).
Additionally, the aberrant RSV budding phenotype we report
occurs without deletion of any of the basic residues surround-
ing the CH motifs. These BRs are known to play importantroles in both RNA packaging and Gag multimerization, and the
MLV mutant phenotype could be a result of the removal of
both BRs and the CH motif. Additionally, Muriaux et al. found
that release defects of the NC mutants could be complemented
by an MLV mutant lacking the late domain. In contrast, we
found that virus production of RSVDCH mutants is not
restored in cells cotransfected with p2 late domain deleted
Gag proviral vector (data not shown), opening up the
possibility that, for RSV, budding utilizes two different
pathways mediated by the two CH motifs and by the classic
L domain in p2. However, effects on the conformation of the
p2 PPPY domain by the CH motif deletion cannot be ruled out.
The DCH virus particles were observed inside of cytoplas-
mic vesicles, and this raises the question as to the cellular
source of such particles. One possibility is that mutant viruses
arrest in the process of budding into endosomal compartments.
Budding into endosomes/multivesicular bodies is now well
established for HIV-1 in macrophages and dendritic (Kwon et
al., 2002; Pelchen-Matthews et al., 2003), but we never
detected budding of DPR wt particles into cytoplasmic
vesicles, making this pathway unlikely. Invaginated structures
seen at the plasma membrane resemble those used for
internalization of membrane proteins of many types, including
signaling receptors, permeases, and transporters. Internalized
cellular proteins are transported to late endosomes which form
vesicles in the lumen, generating a compartment known as the
multivesicular body (MVB) (reviewed in Raiborg et al., 2003).
The MVB then fuses with lysosomes, where the protein cargos
are degraded. By analogy, we hypothesize that, in DCH
mutants, such particles that are not completely detached from
the membrane are recycled into intracellular compartments and
enter the endosomal pathway for salvage.
Materials and methods
DNA constructs
Deletion of either of the two CH motifs was made in the
context of a complete RSV provirus (RSV-PrC; GenBank
accession number J02342) containing neo in the place of the
src gene. The PR domain of Gag was deleted in all of our
constructs (GagDPR). Dp2 lacks all but seven amino acids at
the N-terminus of the p2 domain, in the context of GagDPR.
E.-G. Lee, M.L. Linial / Virology 347 (2006) 226–233232Site-directed mutations in Gag were obtained by two rounds of
PCR using four oligonucleotides. Two outer oligonucleotides
were designed to anneal to the 5V or 3V end of a gag gene with
the addition of two engineered unique restriction sites at each
end. Two inner mutagenic oligonucleotides (in either the
forward or reverse orientation) were designed to be comple-
mentary to the Gag sequences except for the desired mutations.
The first round of DNA amplification was done with a pair of
oligonucleotides consisting of either the 5V outer oligonucleo-
tide and the reverse inner mutagenic oligonucleotide or the
forward inner mutagenic oligonucleotide and the 3V outer
oligonucleotide. The amplified DNAs were then used for a
second round of PCR with the outer oligonucleotides.
Resultant PCR-amplified gag mutated sequences were digested
with the flanking restriction enzymes and ligated to DNA
restriction fragments of the appropriate vectors. Each mutant
construct was sequenced to confirm the presence of the correct
mutational changes.
Yeast two-hybrid binding assays
All gag mutations were fused with an activation domain
(AD), and the late domain interaction (LDI) protein was fused
with a DNA binding domain (DBD) of the yeast two-hybrid
plasmids, using a system previously described (Lee and Linial,
2004). Transformation and a h-galactosidase (h-Gal) filter
assay were performed, as previously described (Lee and Linial,
2004). Filters were incubated at 30 -C, and the appearance of
blue h-Gal-positive colonies on the filters was monitored. At
least four transformants were examined for each interaction in
each experiment.
Cell cultures and transfections
The quail cell line QT6 was grown in Ham’s F-10 medium
containing 10% tryptose phosphate broth (Difco), 5% calf
serum, 1% heat-inactivated chick serum, and 1% dimethy
sulfoxide. Polyfect reagent (Qiagen) was used for DNA
transfections in accordance with the manufacturer’s protocol.
Stably transfected mass cultures of G418-resistant cells, using
0.15 mg/ml G418, were obtained after 2 weeks of selection.
Metabolic radiolabeling of transfected cells and
radioimmunoprecipitation analysis (RIPA)
QT6 cells were labeled with 250 Aci of [35S]-methionine for
5 h and chased for 18 to 20 h, as previously described (Lee and
Linial, 2000). The supernatants were collected, and cell debris
was cleared by low-speed centrifugation and filtration through
a 0.45-Am-pore-diameter syringe filter. Virus was pelleted
through 20% sucrose cushions at 24,000 rpm for 2 h in an L7
ultracentrifuge (Beckman). [35S]-methionine-labeled cell
lysates or virus particles were reacted with anti-RSV PrB
antibody in antibody buffer (20 mM Tris–HCl [pH 7.4], 50
mM NaCl, 0.5% NP-40, 0.5% deoxycholic acid [DOC], 0.5%
SDS, 0.5% aprotinin, 1 mM EDTA [pH 8.0]) with 35 Al of
protein A–sepharose beads (Pharmacia LKB Biotechnology,Inc.) for 2 h at room temperature and assayed as previously
described (Lee and Linial, 2000).
Electron microscopy (EM)
QT6 cells were seeded on plates a day prior to fixing. Cells
were washed with PBS, and once more with 0.1 M cacodylate
buffer, and fixed with 1/2 strength Karnovosky’s fixatives (2%
paraformaldehyde, 2.5% glutaraldehyde) for 2 h at room
temperature. Cells were scraped off the plates and pelleted by
centrifugation at 1200 rpm for 5 min at 4 -C. The cell pellet
was rinsed three times in 0.1 M cacodylate buffer and
dehydrated in graded ethanol (50 to 100%). The pellet was
infiltrated overnight in a 2:1 mixture of LR White resin
(Electron microscopy sciences) and ethanol. The pellet was
then embedded in gelatin capsules and cured in UV light cryo-
chamber at 4 -C. The cured block was thin-sectioned and
stained with uranyl acetate and lead citrate.
For immunoelectron microscopy, the cells were prepared as
described above but fixed with 3% paraformaldehyde plus either
0.025 or 0.05% glutaraldehyde in PBS. The cell pellet was
quickly dehydrated in ethanol and polymerized at 4 -C under UV
light for 18 h with LRWhite resin in gelatin capsules. The cured
block was thin-sectioned and mounted on copper grids. For
immunogold labeling, the grids were blocked in PBS containing
0.1% acetylated bovine serum albumin and 0.1% Tween 20 and
then incubated overnight at 4 -C with undiluted monoclonal
anti-MA serum (AMV-3C2; obtained from the Developmental
Studies Hybridoma Bank, University of Iowa). The grids were
washed in PBS and blocked in the same buffer and incubated for
2.5 h at room temperature with a gold (particle diameter, 10 nm)-
conjugated rabbit anti-mouse antibody (Electron microscopy
sciences). After a wash in the same blocking buffer, the grids
were stained in uranyl acetate and lead citrate for 30 s. Digital
images were obtained with an electron microscope (Jeol 1010)
equipped with a digital camera (Gatan).
Proteasome inhibitor assay
QT6 cells were either untreated or treated with a reversible
proteasome inhibitor MG-132 [carbobenzoxy-l-leucyl-l-leu-
cyl-l-luecinal (zLLL)] at 80 AM for 90 min prior to and during
the metabolic labeling. Cells were labeled with [35S]-methio-
nine for 5 h and chased for 18 to 20 h. Labeled cell lysates and
virus particles were prepared for RIPA.
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